Radiation Risks From Diagnostic Procedures Examined

Share this article:
Radiation Risks From Diagnostic Procedures Examined
Radiation Risks From Diagnostic Procedures Examined

THURSDAY, Feb. 9 (HealthDay News) -- National strategies should be developed for the use of evidence-based criteria and improved oversight of equipment to minimize radiation exposure for patients undergoing diagnostic procedures, according to a study published online Feb. 3 in CA: A Cancer Journal for Clinicians.

Martha S. Linet, M.D., M.P.H., of the National Cancer Institute in Bethesda, Md., and associates reviewed epidemiologic data on cancer risks associated with diagnostic procedures. The authors reviewed the definitions of radiation doses, mechanisms of radiation carcinogenesis, epidemiologic studies of medical and other radiation sources and cancer risks, and diagnostic procedure dose trends. Cancer risks were described in experimental studies, and risks projected from current imaging procedures. They also proposed a framework of strategies to decrease radiation from diagnostic imaging.

To decrease the risk of future cancer from diagnostic procedures, the authors recommend the widespread use of evidence-based appropriateness criteria for decisions about imaging procedures; oversight of equipment to deliver the minimum radiation dose necessary to achieve clinical objectives; development of imaging procedure electronic lifetime records for patients; and a commitment by relevant medical and professional personnel to educate stakeholders in reducing radiation from diagnostic procedures.

"Professionals and professional organizations that play a key role in the appropriate utilization of medical imaging are the referring medical practitioners who are responsible for ensuring that a diagnostic procedure involving ionizing radiation is necessary for a patient's care and should be expected to do more good than harm (designated as justification)," the authors write.

Abstract
Full Text (subscription or payment may be required)

This article originally appeared here.
Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Daily Oncology News

Unplanned hospitalizations among gastrointestinal cancer patients common

Unplanned hospitalizations among gastrointestinal cancer patients common

Among elderly patients with gastrointestinal cancer, unplanned hospitalizations are common, according to online research.

70-Gene signature not likely to be cost-effective for breast cancer

70-Gene signature not likely to be cost-effective for ...

Findings in comparative economic analysis of patients with node-negative breast cancer showed the 70-gene signature is unlikely to be cost-effective for guiding adjuvant chemotherapy decision making.

Many clinicians feel mobile apps can improve patient outcomes

Many clinicians feel mobile apps can improve patient ...

Many physicians believe digital communication technologies, including mobile apps, can be of benefit to their patients.